NCT04733768View on ClinicalTrials.gov

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

August 9, 2022

Study Completion Date

August 9, 2022

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

18F-PSMA-1007

18f-PSMA-1007 PET/CT scan

Trial Locations (1)

T6G 2B7

University of Alberta, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT04733768 - 18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer | Biotech Hunter | Biotech Hunter